LXE408 is an orally active, non-competitive and kinetoplastid-selective proteasome inhibitor. LXE408 has an IC50 of 0.04 µM for L. donovani proteasome and an EC50 of 0.04 µM for L. donovani. LXE408 has a low propensity to cross the blood brain barrier. LXE408 has the potential for visceral leishmaniasis (VL) research[1].
Molekulargewicht:
443.43
Reinheit:
99.75
CAS Nummer:
[1799330-15-6]
Formel:
C23H18FN7O2
Target-Kategorie:
Parasite,Proteasome
Anwendungsbeschreibung:
MCE Product type: Reference compound
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten